Correlation Between Norman Broadbent and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Norman Broadbent and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Norman Broadbent and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Norman Broadbent Plc and Mereo BioPharma Group, you can compare the effects of market volatilities on Norman Broadbent and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Norman Broadbent with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Norman Broadbent and Mereo BioPharma.
Diversification Opportunities for Norman Broadbent and Mereo BioPharma
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Norman and Mereo is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Norman Broadbent Plc and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Norman Broadbent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Norman Broadbent Plc are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Norman Broadbent i.e., Norman Broadbent and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Norman Broadbent and Mereo BioPharma
Assuming the 90 days trading horizon Norman Broadbent Plc is expected to generate 1.1 times more return on investment than Mereo BioPharma. However, Norman Broadbent is 1.1 times more volatile than Mereo BioPharma Group. It trades about -0.03 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.1 per unit of risk. If you would invest 375.00 in Norman Broadbent Plc on October 22, 2024 and sell it today you would lose (25.00) from holding Norman Broadbent Plc or give up 6.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 94.74% |
| Values | Daily Returns |
Norman Broadbent Plc vs. Mereo BioPharma Group
Performance |
| Timeline |
| Norman Broadbent Plc |
| Mereo BioPharma Group |
Norman Broadbent and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Norman Broadbent and Mereo BioPharma
The main advantage of trading using opposite Norman Broadbent and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Norman Broadbent position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| Norman Broadbent vs. Livermore Investments Group | Norman Broadbent vs. JPMorgan Japanese Investment | Norman Broadbent vs. Diversified Energy | Norman Broadbent vs. Infrastrutture Wireless Italiane |
| Mereo BioPharma vs. Cornish Metals | Mereo BioPharma vs. Hochschild Mining plc | Mereo BioPharma vs. Fresenius Medical Care | Mereo BioPharma vs. Panther Metals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |